Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 10 04:00PM ET
6.26
Dollar change
-0.04
Percentage change
-0.63
%
IndexRUT P/E- EPS (ttm)-1.91 Insider Own49.79% Shs Outstand55.59M Perf Week-17.85%
Market Cap348.01M Forward P/E- EPS next Y-1.46 Insider Trans-0.28% Shs Float27.91M Perf Month-33.05%
Income-91.22M PEG- EPS next Q-0.35 Inst Own41.60% Short Float3.52% Perf Quarter-32.47%
Sales25.52M P/S13.64 EPS this Y30.22% Inst Trans2.71% Short Ratio6.27 Perf Half Y5.03%
Book/sh-0.51 P/B- EPS next Y10.50% ROA-29.34% Short Interest0.98M Perf Year11.19%
Cash/sh4.81 P/C1.30 EPS next 5Y- ROE- 52W Range2.70 - 10.25 Perf YTD-2.95%
Dividend Est.- P/FCF- EPS past 5Y-26.80% ROI-4531.69% 52W High-38.93% Beta3.12
Dividend TTM- Quick Ratio4.77 Sales past 5Y328.43% Gross Margin87.51% 52W Low131.85% ATR (14)0.57
Dividend Ex-Date- Current Ratio4.77 EPS Y/Y TTM22.53% Oper. Margin-398.74% RSI (14)29.33 Volatility9.25% 7.88%
Employees116 Debt/Eq- Sales Y/Y TTM-21.66% Profit Margin-357.53% Recom1.29 Target Price16.00
Option/ShortYes / Yes LT Debt/Eq- EPS Q/Q10.52% Payout- Rel Volume0.65 Prev Close6.30
Sales Surprise23.05% EPS Surprise27.91% Sales Q/Q-55.33% EarningsNov 04 AMC Avg Volume156.75K Price6.26
SMA20-18.35% SMA50-20.50% SMA200-9.60% Trades Volume102,547 Change-0.63%
Date Action Analyst Rating Change Price Target Change
Sep-03-24Initiated Jefferies Buy $18
Aug-19-24Initiated Evercore ISI Outperform $20
Mar-28-23Initiated BofA Securities Buy $10
Jan-05-23Initiated BMO Capital Markets Outperform $20
Nov-22-21Initiated H.C. Wainwright Buy $25
Nov-17-20Initiated Wedbush Outperform $24
Nov-17-20Initiated Morgan Stanley Overweight $24
Nov-17-20Initiated Goldman Buy $27
Nov-17-20Initiated Cowen Outperform
Nov-29-24 12:00PM
Nov-25-24 09:55AM
Nov-20-24 08:00AM
06:30AM
Nov-13-24 08:00AM
08:00AM Loading…
08:00AM
Nov-12-24 07:54AM
Nov-04-24 05:25PM
04:05PM
Oct-23-24 08:00AM
Oct-11-24 07:47AM
Oct-10-24 07:00AM
Oct-09-24 07:00AM
Oct-03-24 08:00AM
Oct-01-24 07:00AM
06:00AM Loading…
Sep-26-24 06:00AM
Sep-24-24 09:15AM
Sep-16-24 04:12AM
Sep-11-24 07:02PM
Sep-03-24 07:00AM
Sep-02-24 09:55AM
Aug-28-24 07:00AM
06:30AM
Aug-16-24 09:55AM
Aug-08-24 08:10AM
07:00AM
Aug-06-24 06:30AM
Jul-29-24 07:00AM
Jul-25-24 08:00AM
Jul-23-24 06:00AM
08:00AM Loading…
Jul-17-24 08:00AM
Jul-10-24 06:00AM
06:00AM
Jun-12-24 07:00AM
May-28-24 07:00AM
May-22-24 06:21PM
May-20-24 11:14AM
07:58AM
May-09-24 07:00AM
May-06-24 02:52PM
08:32AM
08:10AM
07:00AM
Apr-16-24 07:00AM
Apr-09-24 04:30PM
Apr-08-24 08:00AM
Apr-05-24 07:00AM
Apr-02-24 09:55AM
Mar-26-24 07:00AM
Mar-19-24 08:30AM
Mar-13-24 12:00PM
09:55AM
Mar-07-24 02:52PM
08:20AM
07:00AM
Mar-05-24 04:48PM
Feb-28-24 07:00AM
Feb-12-24 02:43AM
Feb-09-24 10:02AM
Feb-08-24 07:00AM
Jan-09-24 08:44AM
Jan-08-24 07:00AM
06:30AM
06:30AM
Jan-03-24 04:05PM
Dec-26-23 12:00PM
Dec-11-23 09:55AM
Dec-01-23 07:00AM
Nov-27-23 07:01PM
Nov-21-23 06:00AM
Nov-03-23 06:12AM
Nov-02-23 07:00AM
Nov-01-23 10:30AM
Oct-24-23 08:00AM
Oct-19-23 10:30AM
Oct-13-23 08:00AM
Oct-04-23 08:00AM
Oct-02-23 07:00AM
Sep-27-23 08:31AM
Sep-11-23 06:30AM
Sep-05-23 08:00AM
Aug-31-23 07:00AM
Aug-29-23 09:00AM
Aug-11-23 03:54PM
Aug-08-23 07:00AM
Aug-04-23 08:15AM
07:00AM
Jul-09-23 07:58PM
Jun-28-23 01:44PM
07:00AM
Jun-07-23 08:00AM
Jun-06-23 07:56AM
Jun-05-23 07:00AM
May-16-23 06:00AM
May-10-23 07:47AM
May-08-23 08:15AM
07:00AM
Apr-27-23 04:35AM
Apr-25-23 04:05PM
Apr-24-23 01:28PM
Foghorn Therapeutics, Inc. operates as a development stage biopharmaceutical company. It is discovering and developing a novel class of precision medicine therapeutics targeting the chromatin regulatory system in oncology. Through its scalable Gene Traffic Control product platform, the firm is systematically interrogating and drugging the chromatin regulatory system. The company was founded by Cigall Kadoch, Gerald W. Crabtree and Douglas G. Cole in October 2015 and is headquartered in Cambridge, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Costa CarlosChief People OfficerSep 20 '24Option Exercise3.7235,756133,01235,756Sep 24 04:01 PM
Costa CarlosChief People OfficerSep 23 '24Option Exercise3.728573,188857Sep 24 04:01 PM
Costa CarlosChief People OfficerSep 20 '24Sale10.0435,756358,9900Sep 24 04:01 PM
Costa CarlosChief People OfficerSep 23 '24Sale10.178578,7160Sep 24 04:01 PM
Costa CarlosChief People OfficerSep 18 '24Option Exercise3.7211,57443,05511,574Sep 20 04:00 PM
Costa CarlosChief People OfficerSep 18 '24Sale10.0511,574116,3190Sep 20 04:00 PM
Costa CarlosChief People OfficerSep 17 '24Option Exercise3.7210,27238,21210,272Sep 18 04:01 PM
Costa CarlosChief People OfficerSep 16 '24Option Exercise3.724001,488400Sep 18 04:01 PM
Costa CarlosChief People OfficerSep 17 '24Sale10.0410,272103,1310Sep 18 04:01 PM
Costa CarlosChief People OfficerSep 16 '24Sale10.004004,0000Sep 18 04:01 PM
CARLOS COSTAOfficerSep 16 '24Proposed Sale9.7298,648958,859Sep 16 04:40 PM
Bellon Steven F.Chief Scientific OfficerSep 09 '24Sale9.5020,000190,000101,957Sep 11 04:00 PM
STEVEN BELLONOfficerSep 09 '24Proposed Sale7.5320,000150,600Sep 09 04:31 PM
Cavalie FannyChief Strategy/Bus Ops OfficerMar 11 '24Sale6.5611,00072,13475,992Mar 12 04:19 PM